Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India

PHASE4CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

February 11, 2022

Study Completion Date

March 12, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

Vortioxetine

5 - 20 mg/day flexible-dose vortioxetine, tablets, orally

Trial Locations (24)

110026

Maharaja Agarsen Hospital (IN1021), Delhi

141001

Dayanand Medical College and Hospital (IN024), Ludhiana

221005

Deva Institute of Healthcare and Research PVT ltd. (IN1005), Varanasi

360001

Nagecha Hospital, Creative Chamber (IN1015), Rajkot

362001

Shree Hatkesh Health Foundation (IN1016), Jūnāgadh

380008

Ratandeep Multispecialty Hospital (IN1002), Ahmedabad

380013

MITR Foundation 1 (IN1013), Ahmedabad

380016

BJ Medical College and Civil Hospital (IN028), Ahmedabad

390021

GMERS Medical College and Hospital,Department of Psychiatry (IN1004), Vadodara

395001

Divyam Clinic (IN1025), Surat

411004

Lata Mangeshkar Medical Foundation's (IN1001), Pune

411005

Oyster and Pearl Hospital (IN1014), Pune

422005

Chopda Medicare & Research Centre (IN023), Nashik

431005

Society for Psychiatric Update and Research, Shanti Nursing Home (IN1008), Aurangabad

440010

Arneja Heart and Multispeciality Hospital (IN1022), Nagpur

Central Institute of Behavioural Sciences (IN1019), Nagpur

500034

ASHA hospital (IN1018), Hyderabad

570001

Department of Psychiatry K R Hospital Mysore Medical College and Research Institute (IN1020), Mysuru

575003

Mangala Hospital & Mangala Kidney Foundation (IN1006), Mangalore

575018

K. S. Hegde Medical Academy (IN1003), Mangalore

673009

IQRAA International Hospital & Research Centre (IN030), Kozhikode

700020

Institute of Post Graduate Medical Education and Research (IN1026), Kolkata

560 022

People Tree Hospitals (IN1027), Bengaluru

575 003

Vinaya Hospital & Research Centre (IN1007), Mangalore

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT04288895 - Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India | Biotech Hunter | Biotech Hunter